相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 in patients with rheumatological diseases treated with anti-TNF
Carlos Antunes Brito et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Ahmet Kursat Azkur et al.
ALLERGY (2020)
Pharmacotherapy in COVID-19; A narrative review for emergency providers
Nikita Mehta et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
Marcus R. Pereira et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
Pierre-Marie Duret et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2
David A. Schwartz
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
John L. Sapp et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Brandon Michael Henry et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N. Lian et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
The role of interleukin-6 in monitoring severe case of coronavirus disease 2019
Tao Liu et al.
EMBO MOLECULAR MEDICINE (2020)
Rethinking the role of hydroxychloroquine in the treatment of COVID-19
Eric A. Meyerowitz et al.
FASEB JOURNAL (2020)
Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
Antonio Tursi et al.
INFLAMMATORY BOWEL DISEASES (2020)
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
Farhad Seif et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
The epidemiology, diagnosis and treatment of COVID-19
Pan Zhai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
Zhen Zhu et al.
JOURNAL OF INFECTION (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab
Michael T. Dolinger et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Khan Sharun et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Ashley Barlow et al.
PHARMACOTHERAPY (2020)
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1
Leonard H. Calabrese et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
COVID-19: Immunology and treatment options
Susanna Felsenstein et al.
CLINICAL IMMUNOLOGY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Is a Cytokine Storm Relevant to COVID-19?
Pratik Sinha et al.
JAMA INTERNAL MEDICINE (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
Dongyuan Wang et al.
Journal of Infection and Public Health (2020)
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
Saeed K. Alzghari et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
F. La Rosee et al.
LEUKEMIA (2020)
Interleukin-6 as a potential biomarker of COVID-19 progression
Zulvikar Syambani Ulhaq et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
The COVID-19 Pandemic: Consideration for Brain Infection
Xiao-Yuan Mao et al.
NEUROSCIENCE (2020)
Natural History of Asymptomatic SARS-CoV-2 Infection
Aki Sakurai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee et al.
PHARMACOLOGICAL RESEARCH (2020)
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries
Michael C. Grant et al.
PLOS ONE (2020)
Treatment for emerging viruses: Convalescent plasma and COVID-19
Bethany L. Brown et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Respiratory failure and non-invasive respiratory support during the covid-19 pandemic: an update for re-deployed hospital doctors and primary care physicians
Thomas W. Nicholson et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Joseph Magagnoli et al.
MED (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Potential Pharmacological Agents for COVID-19
Anita Kotwani et al.
INDIAN JOURNAL OF PUBLIC HEALTH (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
Luke Adam Monteagudo et al.
ACR OPEN RHEUMATOLOGY (2020)
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
R. Choudhary et al.
NEW MICROBES AND NEW INFECTIONS (2020)
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis
Marie Lecronier et al.
CRITICAL CARE (2020)
Antiviral treatment of COVID-19
Serap Simsek Yavuz et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes
C. -H. Jang et al.
RHEUMATOLOGY (2006)
分享论文
